Narrow search
Showing 1 - 6 of 6
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Innovation under regulatory uncertainty : evidence from medical technology
Stern, Ariel D. - 2015
Persistent link: https://www.econbiz.de/10011305279
Cover Image
Who drives digital innovation? : evidence from the U.S. medical device industry
Foroughi, Cirrus; Stern, Ariel D. - 2019
Persistent link: https://www.econbiz.de/10012064942
Cover Image
Recalls, innovation, and competitor response : evidence from medical device firms
Ball, George P.; Macher, Jeffrey T.; Stern, Ariel D. - 2019
Persistent link: https://www.econbiz.de/10012013491
Cover Image
Which Markets (Don't) Drive Pharmaceutical Innovation? Evidence From U.S. Medicaid Expansions
Garthwaite, Craig; Sachs, Rebecca; Stern, Ariel D. - National Bureau of Economic Research - 2021
Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …
Persistent link: https://www.econbiz.de/10012533304
Cover Image
Regulatory Incentives for Innovation : The FDA's Breakthrough Therapy Designation
Chandra, Amitabh; Kao, Jennifer L.; Miller, Kathleen L.; … - National Bureau of Economic Research - 2022
clinical trial design complexity. The results suggest that targeted regulatory innovation can shorten R&D periods without …
Persistent link: https://www.econbiz.de/10013477204